BSX
66
-3
MUR
43
17
CMA
40
3
CVX
25
3
FLR
38
2
HOG
33
2
MNST
59
3
TSN
38
3
D
37
2
C
40
4
VFC
58
13
REGN
68
3
AZO
63
11
BIIB
36
3
FMC
30
6
HBI
45
8
EFX
66
11
CHK
12
9
JPM
62
2
GE
65
-5
BSX
66
-3
MUR
43
17
CMA
40
3
CVX
25
3
FLR
38
2
HOG
33
2
MNST
59
3
TSN
38
3
D
37
2
C
40
4
VFC
58
13
REGN
68
3
AZO
63
11
BIIB
36
3
FMC
30
6
HBI
45
8
EFX
66
11
CHK
12
9
JPM
62
2
GE
65
-5
Financhill
Back

SPDR S&P® North American Natural Res ETF Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
39

NANR
SPDR S&P® North American Natural Res ETF

Last Price:
54.55
Seasonality Move:
1.37%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.82
Seasonality Move:
-0.9%
Sell
39
SPDR S&P® North American Natural Res ETF (NANR) is a Sell

Is SPDR S&P® North American Natural Res ETF a Buy, Sell or Hold?

  • The current SPDR S&P® North American Natural Res ETF [NANR] share price is $55.05. The Score for NANR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • NANR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.39. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NANR Stock Price Chart

What is SPDR S&P® North American Natural Res ETF's stock price today?

  • The SPDR S&P® North American Natural Res ETF share price today is $55.05
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NANR is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

NANR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.65 Sell
Relative Strength Index (14 RSI): 50.37 Buy
Chaikin Money Flow: 9336 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.74 - 57.18) Sell
Bollinger Bands (100): (50.11 - 56.93) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.74 Sell
Relative Strength Index (14 RSI): 45.16 Sell
Chaikin Money Flow: -377368 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.89 - 42.13) Sell
Bollinger Bands (100): (40.93 - 48.81) Sell

NANR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.71 Buy
20-day SMA: 54.9 Buy
50-day SMA: 55.91 Sell
200-day SMA: 52.24 Buy
8-day EMA: 54.14 Buy
20-day EMA: 54.74 Buy
50-day EMA: 55.04 Buy
200-day EMA: 53.18 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.13 Sell
20-day SMA: 40.38 Sell
50-day SMA: 41.72 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.68 Sell
20-day EMA: 40.43 Sell
50-day EMA: 41.92 Sell
200-day EMA: 43.42 Sell

SPDR S&P® North American Natural Res ETF Earnings Growth & NANR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

SPDR S&P® North American Natural Res ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):